This report was recently updated on December 14 2024 with the latest and most recent
market numbers
Global Somatic Cancer Mutation Testing Market Size, Trends & Analysis - Forecasts to 2027 By Product (Instruments & Platforms, Reagents & Other Consumables), By Type (Hematological Cancer Profiling, Solid Tumor Profiling), By Technology (NGS, PCR & RT PCR, IHC, Others), By Indication (Breast Cancer, Ovarian, Prostate, Lung Cancer, Others), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis
The global somatic cancer mutation testing market is projected to grow at a CAGR of 9.5% from 2022 to 2027.
The growing demand for clinical diagnostic testing for cancer mutations, increasing adoption of NGS in cancer diagnostics, growing demand for genetic mutation diagnostics, and the advancements in medical diagnostic technologies have been instrumental in the rapid development of the global somatic cancer mutation testing market.
The growing incidence of cancer among the population has been instrumental in increasing willingness among public and private entities to prioritize cancer research investments in recent years. A positive market impact has been observed from the increasing number of partnerships between pharmaceutical firms and academic institutions for the development of innovative cancer mutation diagnostics. According to information provided by the American Cancer Society, there will likely be 1.9 million new instances of cancer in the United States alone. It is anticipated that there will be 609,360 fatalities caused by carcinogenic growths in the United States in 2022. According to figures from the WHO, approximately 10 million deaths worldwide were brought on by cancer in 2020. Lung, breast, colon, and prostate cancers are the most prevalent types of cancer that affect people.
The growing adoption of bioinformatics and analysis software in cancer diagnostics has streamlined diagnostic analysis, allowed for faster clearance rates, and is making diagnostic testing more cost-effective. The advantages of using popular software such as Varscan 2 and MuTect are expected to allow for rapid development in the somatic cancer mutation testing market.
The development of solutions to overcome sensitivity restraints in next-generation sequencing technologies is expected to further increase the adoption of somatic cancer mutation testing solutions. The development of novel solutions such as enriching liquid biopsies is expected to provide lucrative growth opportunities in the market during the forecast period.
The market is restrained by the high cost of diagnostic testing tools, government regulations, and the lack of skilled professionals in the market.
Many pharmaceutical and biotechnology businesses have seen their earnings skyrocket as a result of the COVID-19 epidemic. Healthcare as a whole has grown rapidly as a result of the epidemic, although several areas of the business, such as oncology, had to take a back seat while the globe concentrated on lessening the pandemic's effects. Due to the increased funding availability, pharmaceutical and biotechnology firms are anticipated to expand their investment in the development of innovative cancer treatments and diagnostics as the world begins to return to normal. Treatments for patients that had been postponed are gradually being finished and resumed. The influence of COVID and the rising incidence of cancer among the elderly population are both anticipated to drive up demand for somatic cancer mutation testing.
The instruments & platforms segment is expected to witness the largest share in the global somatic cancer mutation testing market during the forecast period, based on product. Platforms & instruments are being increasingly employed by hospitals, clinics, research institutions, and biotechnology companies. The rising demand for updating older models and the growing demand for new cancer diagnostics technologies have resulted in the rapid growth of the instruments & platforms segment.
The growing number of laboratories across the globe stemming from increasing investment in the healthcare sector due to COVID is also expected to result in the instruments & platforms segment holding the fastest-growing segment in the market, based on product.
The hematological cancer profiling segment is expected to hold the largest share in the market, based on type. The rapid adoption of NGS for cancer diagnostics has led to this segment dominating the market. Hematological cancer profiling allows researchers to analyze hundreds of samples in one at a cost-effective rate. The growing demand for genetic resting in newborn babies has also played a vital role in the growth of the hematological cancer profiling segment.
The solid tumor profiling segment is expected to grow the fastest in the market, based on type. The growing number of cancer patients across the globe and the increased chance of mutation in carcinogenic growths are expected to increase the demand for solid tumor profiling.
The NGS segment is expected to witness the largest share in the global somatic cancer mutation testing market, based on technology. The use of next-generation sequencing (NGS) as a useful tool for analyzing somatic mutations in cancer is growing. NGS provides excellent data quality, simplicity of use, and great sensitivity for successfully finding even uncommon mutations. These benefits are encouraging NGS to be used more often in clinical cancer studies.
The PCR & RT PCR segment is expected to grow the fastest, based on technology. The growing demand for PCR in enriching samples for mutation studies is expected to lead to the rapid adoption of this segment in the market. These solutions will allow for the easier detection of unknown mutations by bringing up their presence to detectable levels in samples.
The breast cancer segment is expected to witness the largest share in the global somatic cancer mutation testing market, based on the indication. The growing incidence of breast cancer and the probability of it being genetically passed on has led to the rapid adoption of somatic cancer mutation testing in breast cancer applications.
The lung cancer segment is expected to grow the fastest, based on the indication. The growing incidence of lung cancer in the population and the high rate of fatality are expected to lead to the rapid growth of the lung cancer segment.
The North American region is expected to witness the largest share in the global somatic cancer mutation testing market during the forecast period of 2022-2027. The region’s highly developed healthcare industry, presence of major players, heavy investment in somatic cancer testing, and string intellectual property protection laws are the major drivers of the North American market.
The growing incidence of breast cancer, lung cancer, and other forms of cancer in the United States combined with the rapid technological advancement and research output in the country has led to the United States dominating the North American region.
Asia-Pacific is expected to grow the fastest during 2022-2027. The APAC region's growing geriatric population and the growing number of cancer research institutions, and increased investment in cancer research are expected to contribute to the rapid growth of the market in the APAC region.
Thermo Fisher Scientific, Inc., Illumina, Inc., Invitae Corporation, F. Hoffmann-La Roche Ltd., MedGenome, CENTOGENE N.V., Myriad Genetics, Inc., eviCore healthcare, CeGaT GmbH, QIAGEN, among others, are key players in the global somatic cancer mutation testing market.
Please note: This is not an exhaustive list of companies profiled in the report.
Chapter 1 Research Methodology
1.1 Research Assumptions
1.2 Research Methodology
1.2.1 Estimates and Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GME’s Internal Database
1.3.3 Primary Research
1.3.4 Secondary Sources & Third-Party Perspectives
1.3.4.1 Company Information Sources: Annual Reports, Investor Presentation, Press Release, SEC Filing, Company Blogs & Website
1.3.4.2 Secondary Data Sources: World Health Organization, Laboratory Corporation of America Holdings
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Type & Data Visualization
1.6 Data Validation & Publishing
1.7 Market Model
1.7.1 Model Details
1.7.1.1 Top-Down Approach
1.7.1.2 Bottom-Up Approach
1.8 Market Segmentation & Scope
1.9 Market Definition
Chapter 2 Executive Summary
2.1. Global Market Outlook
2.2 Indication Outlook
2.3 Technology Outlook
2.4 Type Outlook
2.5 Product Outlook
2.6 Regional Outlook
Chapter 3 Global Somatic Cancer Mutation Testing Market Trend Analysis
3.1. Market Introduction
3.2 Penetration & Growth Prospect Mapping
3.3 Impact of COVID-19 on the Somatic Cancer Mutation Testing Market
3.4 Metric Data on Healthcare Industry
3.5 Market Dynamic
3.5.1 Market Driver Analysis
3.5.2 Market Restraint Analysis
3.5.3 Industry Challenges
3.5.4 Industry Opportunities
3.6 Porter’s Five Analysis
3.6.1 Supplier Power
3.6.2 Buyer Power
3.6.3 Substitution Threat
3.6.4 Threat from New Entrant
3.7 Market Entry Strategies
Chapter 4 Somatic Cancer Mutation Testing Market: Indication Trend Analysis
4.1 Indication: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027
4.2 Breast Cancer
4.2.1 Market Estimates & Forecast Analysis of Breast Cancer Segment, By Region, 2019-2027 (USD Billion)
4.3 Ovarian
4.3.1 Market Estimates & Forecast Analysis of Ovarian Markets Segment, By Region, 2019-2027 (USD Billion)
4.4 Ovarian
4.4.1 Market Estimates & Forecast Analysis of Ovarian Markets Segment, By Region, 2019-2027 (USD Billion)
4.5 Prostate
4.5.1 Market Estimates & Forecast Analysis of Prostate Markets Segment, By Region, 2019-2027 (USD Billion)
4.6 Lung Cancer
4.6.1 Market Estimates & Forecast Analysis of Lung Cancer Markets Segment, By Region, 2019-2027 (USD Billion)
4.7 Others
4.7.1 Market Estimates & Forecast Analysis of Others Markets Segment, By Region, 2019-2027 (USD Billion)
Chapter 5 Somatic Cancer Mutation Testing Market: Technology Trend Analysis
5.1 Technology: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027
5.2 NGS
5.2.1 Market Estimates & Forecast Analysis of NGS Segment, By Region, 2019-2027 (USD Billion)
5.3 PCR & RT PCR
5.3.1 Market Estimates & Forecast Analysis of PCR & RT PCR Segment, By Region, 2019-2027 (USD Billion)
5.4 IHC
5.4.1 Market Estimates & Forecast Analysis of IHC Segment, By Region, 2019-2027 (USD Billion)
5.5 Others
5.5.1 Market Estimates & Forecast Analysis of Others Segment, By Region, 2019-2027 (USD Billion)
Chapter 6 Somatic Cancer Mutation Testing Market: Type Trend Analysis
6.1 Type: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027
6.2 Hematological Cancer Profiling
6.2.1 Market Estimates & Forecast Analysis of Hematological Cancer Profiling Segment, By Region, 2019-2027 (USD Billion)
6.3 Solid Tumor Profiling
6.3.1 Market Estimates & Forecast Analysis of Governance, Solid Tumor Profiling Segment, By Region, 2019-2027 (USD Billion)
Chapter 7 Somatic Cancer Mutation Testing Market: Product Trend Analysis
7.1 Product: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027
7.2 Instruments & Platforms
7.2.1 Market Estimates & Forecast Analysis of Instruments & Platforms Segment, By Region, 2019-2027 (USD Billion)
7.3 Reagents & Other Consumables
7.3.1 Market Estimates & Forecast Analysis of Reagents & Other Consumables Segment, By Region, 2019-2027 (USD Billion)
Chapter 9 Somatic Cancer Mutation Testing Market, By Region
8.1 Regional Outlook
8.2 North America
8.2.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)
8.2.2 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.2.3 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.2.4 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.2.5 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.2.6 U.S.
8.2.6.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.2.6.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.2.6.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.2.6.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.2.7 Canada
8.2.7.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.2.7.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.2.7.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.2.7.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.2.8 Mexico
8.2.8.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)
8.2.8.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027 (USD Billion)
8.2.8.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)
8.2.8.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.3 Europe
8.3.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)
8.3.2 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.3.3 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.3.4 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.3.5 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.3.6 Germany
8.3.6.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.3.6.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.3.6.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.3.6.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.3.7 UK
8.3.7.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.3.7.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.3.7.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.3.7.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.3.8 France
8.3.8.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.3.8.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.3.8.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.3.8.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.3.9 Netherlands
8.3.9.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.3.9.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.3.9.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.3.9.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.3.10 Italy
8.3.10.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.3.10.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.3.10.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.3.10.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.3.11 Spain
8.3.11.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.3.11.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.3.11.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.3.11.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.3.12 Rest of Europe
8.3.12.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)
8.3.12.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027 (USD Billion)
8.3.12.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)
8.3.12.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.4 Asia Pacific
8.4.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)
8.4.2 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.4.3 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.4.4 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.4.5 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.4.6 China
8.4.6.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.4.6.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.4.6.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.4.6.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.4.7 India
8.4.7.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.4.7.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.4.7.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.4.7.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.4.8 Japan
8.4.8.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.4.8.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.4.8.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.4.8.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.4.9 Thailand
8.4.9.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.4.9.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.4.9.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.4.9.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.4.10 South Korea
8.4.10.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.4.10.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.4.10.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.4.10.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.4.11 Indonesia
8.4.11.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.4.11.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.4.11.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.4.11.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.4.12 Malaysia
8.4.12.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.4.12.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.4.12.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.4.12.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.4.13 Singapore
8.4.13.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.4.13.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.4.13.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.4.13.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.4.14 Vietnam
8.4.14.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.4.14.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.4.14.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.4.14.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.4.15 Rest of Asia Pacific
8.4.15.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)
8.4.15.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027 (USD Billion)
8.4.15.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)
8.4.15.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.5 Central & South America
8.5.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)
8.5.2 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.5.3 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.5.4 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.5.5 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.5.6 Brazil
8.5.6.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.5.6.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.5.6.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.5.6.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.5.7 Argentina
8.5.7.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.5.7.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.5.7.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.5.7.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.5.8 Chile
8.5.8.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.5.8.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.5.8.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.5.8.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.5.7 Rest of Central & South America
8.5.7.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.5.7.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.5.7.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.5.7.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.6 Middle East & Africa
8.6.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)
8.6.2 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.6.3 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.6.4 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.6.5 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.6.6 Saudi Arabia
8.6.6.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.6.6.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.6.6.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.6.6.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.6.7 United Arab Emirates
8.6.7.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.6.7.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.6.7.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.6.7.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.6.8 South Africa
8.6.8.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.6.8.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.6.8.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.6.8.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.6.8 Israel
8.6.9.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027(USD Billion)
8.6.9.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027(USD Billion)
8.6.9.3 Market Estimates & Forecast Analysis, By Type, 2019-2027(USD Billion)
8.6.9.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
8.6.10 Rest of Middle East & Africa
8.6.10.1 Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)
8.6.10.2 Market Estimates & Forecast Analysis, By Technology, 2019-2027 (USD Billion)
8.6.10.3 Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)
8.6.10.4 Market Estimates & Forecast Analysis, By Product, 2019-2027(USD Billion)
Chapter 9 Competitive Analysis
9.1 Key Global Players, Recent Developments & their Impact on the Industry
9.2 Four Quadrant Competitor Positioning Matrix
9.2.1 Key Innovators
9.2.2 Market Leaders
9.2.3 Emerging Players
9.2.4 Market Challengers
9.3 Vendor Landscape Analysis
9.4 Product Landscape Analysis
9.5 Company Market Share Analysis, 2021
Chapter 10 Company Profile Analysis
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Strategic Initiatives
10.1.4 Product Benchmarking
10.2 Illumina, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Strategic Initiatives
10.2.4 Product Benchmarking
10.3 Invitae Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Strategic Initiatives
10.3.4 Product Benchmarking
10.4 F. Hoffmann-La Roche Ltd.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Strategic Initiatives
10.4.4 Product Benchmarking
10.5 MedGenome
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Strategic Initiatives
10.5.4 Product Benchmarking
10.6 CENTOGENE N.V.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Strategic Initiatives
10.6.4 Product Benchmarking
10.7 Myriad Genetics, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Strategic Initiatives
10.7.4 Product Benchmarking
10.8 eviCore healthcare
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Strategic Initiatives
10.8.4 Product Benchmarking
10.9 CeGaT GmbH
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Strategic Initiatives
10.9.4 Product Benchmarking
10.10 QIAGEN
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Strategic Initiatives
10.10.4 Product Benchmarking
10.11 Other Companies
10.11.1 Company Overview
10.11.2 Financial Analysis
10.11.3 Strategic Initiatives
10.11.4 Product Benchmarking
List of Tables
1 Technological Advancements in Somatic Cancer Mutation Testing Market
2 Global Somatic Cancer Mutation Testing Market: Key Market Drivers
3 Global Somatic Cancer Mutation Testing Market: Key Market Challenges
4 Global Somatic Cancer Mutation Testing Market: Key Market Opportunities
5 Global Somatic Cancer Mutation Testing Market: Key Market Restraints
6 Global Somatic Cancer Mutation Testing Market Estimates & Forecast Analysis, 2019-2027 (USD Billion)
7 Global Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
8 Breast Cancer: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
9 Ovarian Markets: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
10 Prostate: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
11 Lung Cancer: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
12 Others: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
13 Global Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
14 NGS: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
15 PCR & RT PCR: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
16 IHC: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
17 Others: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
18 Global Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
19 Hematological Cancer Profiling: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
20 Solid Tumor Profiling: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
21 Global Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
22 Reagents & Other Consumables: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
23 Others: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
24 Clinics, and Research Centres: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
25 Regional Analysis: Global Somatic Cancer Mutation Testing Market, By Region, 2019-2027 (USD Billion)
26 North America: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
27 North America: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
28 North America: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
29 North America: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
30 North America: Somatic Cancer Mutation Testing Market, By Country, 2019-2027 (USD Billion)
31 U.S: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
32 U.S: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
33 U.S: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
34 U.S: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
35 Canada: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
36 Canada: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
37 Canada: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
38 Canada: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
39 Mexico: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
40 Mexico: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
41 Mexico: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
42 Mexico: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
43 Europe: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
44 Europe: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
45 Europe: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
46 Europe: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
47 Germany: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
48 Germany: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
49 Germany: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
50 Germany: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
51 UK: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
52 UK: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
53 UK: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
54 UK: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
55 France: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
56 France: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
57 France: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
58 France: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
59 Italy: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
60 Italy: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
61 Italy: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
62 ltaly: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
63 Spain: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
64 Spain: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
65 Spain: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
66 Spain: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
67 Netherlands: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
68 Netherlands: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
69 Netherlands: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
70 Netherlands: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
71 Rest Of Europe: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
72 Rest Of Europe: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
73 Rest Of Europe: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
74 Rest of Europe: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
75 Asia Pacific: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
76 Asia Pacific: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
77 Asia Pacific: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
78 Asia Pacific: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
79 Asia Pacific: Somatic Cancer Mutation Testing Market, By Country, 2019-2027 (USD Billion)
80 China: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
81 China: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
82 China: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
83 China: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
84 India: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
85 India: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
86 India: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
87 India: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
88 Japan: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
89 Japan: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
90 Japan: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
91 Japan: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
92 South Korea: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
93 South Korea: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
94 South Korea: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
95 South Korea: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
96 Thailand: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
97 Thailand: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
98 Thailand: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
99 Thailand: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
100 Indonesia: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
101 Indonesia: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
102 Indonesia: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
103 Indonesia: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
104 Malaysia: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
105 Malaysia: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
106 Malaysia: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
107 Malaysia: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
108 Singapore: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
109 Singapore: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
110 Singapore: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
111 Singapore: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
112 Vietnam: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
113 Vietnam: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
114 Vietnam: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
115 Vietnam: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
116 Rest of Asia Pacific: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
117 Rest of Asia Pacific: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
118 Rest of Asia Pacific: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
119 Rest of Asia Pacific: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
120 Middle East & Africa: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
121 Middle East & Africa: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
122 Middle East & Africa: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
123 Middle East & Africa: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
124 Middle East & Africa: Somatic Cancer Mutation Testing Market, By Country, 2019-2027 (USD Billion)
125 Saudi Arabia: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
126 Saudi Arabia: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
127 Saudi Arabia: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
128 Saudi Arabia: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
129 UAE: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
130 UAE: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
131 UAE: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
132 UAE: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
133 South Africa: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
134 South Africa: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
135 South Africa: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
136 South Africa: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
137 Israel: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
138 Israel: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
139 Israel: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
140 Israel: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
141 Rest of Middle East & Africa: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
142 Rest of Middle East & Africa: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
143 Rest of Middle East & Africa: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
144 Rest of Middle East & Africa: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
145 Central & South America: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
146 Central & South America: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
147 Central & South America: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
148 Central & South America: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
149 Central & South America: Somatic Cancer Mutation Testing Market, By Country, 2019-2027 (USD Billion)
150 Brazil: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
151 Brazil: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
152 Brazil: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
153 Brazil: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
154 Argentina: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
155 Argentina: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
156 Argentina: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
157 Argentina: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
158 Chile: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
159 Chile: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
160 Chile: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
161 Chile: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
162 Rest of Central & South America: Somatic Cancer Mutation Testing Market, By Indication, 2019-2027 (USD Billion)
163 Rest of Central & South America: Somatic Cancer Mutation Testing Market, By Technology, 2019-2027 (USD Billion)
164 Rest of Central & South America: Somatic Cancer Mutation Testing Market, By Type, 2019-2027 (USD Billion)
165 Rest of Central & South America: Somatic Cancer Mutation Testing Market, By Product, 2019-2027 (USD Billion)
166 Thermo Fisher Scientific, Inc.: Products Offered
167 Illumina, Inc.: Products Offered
168 Invitae Corporation: Products Offered
169 F. Hoffmann-La Roche Ltd.: Products Offered
170 MedGenome: Products Offered
171 CENTOGENE N.V.: Products Offered
172 Myriad Genetics, Inc.: Products Offered
173 eviCore healthcare: Products Offered
174 CeGaT GmbH: Products Offered
175 QIAGEN : Products Offered
176 Analog Devices, Inc: Products Offered
177 Other Companies: Products Offered
List of Figures
1. Global Somatic Cancer Mutation Testing Market Segmentation & Research Scope
2. Primary Research Partners and Local Informers
3. Primary Research Process
4. Primary Research Approaches
5. Primary Research Responses
6. Global Somatic Cancer Mutation Testing Market: Penetration & Growth Prospect Mapping
7. Global Somatic Cancer Mutation Testing Market: Value Chain Analysis
8. Global Somatic Cancer Mutation Testing Market Drivers
9. Global Somatic Cancer Mutation Testing Market Restraints
10. Global Somatic Cancer Mutation Testing Market Opportunities
11. Global Somatic Cancer Mutation Testing Market Challenges
12. Key Somatic Cancer Mutation Testing Market Manufacturer Analysis
13. Global Somatic Cancer Mutation Testing Market: Porter’s Five Forces Analysis
14. PESTLE Analysis & Impact Analysis
15. Thermo Fisher Scientific, Inc.: Company Snapshot
16. Thermo Fisher Scientific, Inc.: Swot Analysis
17. Illumina, Inc.: Company Snapshot
18. Illumina, Inc.: Swot Analysis
19. Invitae Corporation: Company Snapshot
20. Invitae Corporation: Swot Analysis
21. F. Hoffmann-La Roche Ltd.: Company Snapshot
22. F. Hoffmann-La Roche Ltd.: Swot Analysis
23. MedGenome: Company Snapshot
24. MedGenome: Swot Analysis
25. CENTOGENE N.V.: Company Snapshot
26. CENTOGENE N.V.: Swot Analysis
27. Myriad Genetics, Inc.: Company Snapshot
28. Myriad Genetics, Inc.: Swot Analysis
29. TE CONNECTIVITY: Company Snapshot
30. TE CONNECTIVITY: Swot Analysis
31. CeGaT GmbH: Company Snapshot
32. CeGaT GmbH: Swot Analysis
33. Enchandia AB Software: Company Snapshot
34. Enchandia AB Software: Swot Analysis
35. QIAGEN : Company Snapshot
36. QIAGEN : Swot Analysis
37. Analog Devices, Inc: Company Snapshot
38. Analog Devices, Inc: Swot Analysis
39. Other Companies: Company Snapshot
40. Other Companies: Swot Analysis
The Global Somatic Cancer Mutation Testing Market has been studied from the year 2019 till 2027. However, the CAGR provided in the report is from the year 2022 to 2027. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Somatic Cancer Mutation Testing Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
